FT
BSX icon

Fiduciary Trust’s Boston Scientific BSX Stock Holding History

Fiduciary Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
54,971
+33,978
+162% +$1.85M 0.03% 261
2026
Q1 		$1.32M Buy
20,993
+15,835
+307% +$1.27M 0.02% 361
2025
Q4 		$492K Sell
5,158
-3,177
-38% -$311K 0.01% 566
2025
Q3 		$814K Buy
8,335
+439
+6% +$45.5K 0.01% 455
2025
Q2 		$848K Sell
7,896
-25
-0.3% -$2.53K 0.01% 434
2025
Q1 		$799K Sell
7,921
-132
-2% -$13.3K 0.01% 432
2024
Q4 		$719K Hold
8,053
– – 0.01% 422
2024
Q3 		$675K Sell
8,053
-72
-0.9% -$5.68K 0.01% 433
2024
Q2 		$626K Buy
8,125
+300
+4% +$22K 0.01% 414
2024
Q1 		$536K Buy
7,825
+499
+7% +$32.1K 0.01% 444
2023
Q4 		$424K Hold
7,326
– – 0.01% 476
2023
Q3 		$387K Sell
7,326
-1,642
-18% -$86.1K 0.01% 482
2023
Q2 		$485K Sell
8,968
-500
-5% -$26.1K 0.01% 449
2023
Q1 		$474K Sell
9,468
-419
-4% -$19.7K 0.01% 446
2022
Q4 		$457K Sell
9,887
-206
-2% -$8.92K 0.01% 467
2022
Q3 		$391K Sell
10,093
-14,448
-59% -$580K 0.01% 474
2022
Q2 		$914K Buy
24,541
+2,462
+11% +$100K 0.02% 342
2022
Q1 		$978K Buy
22,079
+14,055
+175% +$609K 0.02% 356
2021
Q4 		$341K Sell
8,024
-12,656
-61% -$532K 0.01% 536
2021
Q3 		$898K Buy
20,680
+163
+0.8% +$7.21K 0.02% 352
2021
Q2 		$877K Hold
20,517
– – 0.02% 355
2021
Q1 		$793K Buy
20,517
+5,521
+37% +$209K 0.02% 369
2020
Q4 		$539K Sell
14,996
-4,809
-24% -$173K 0.01% 422
2020
Q3 		$757K Buy
19,805
+8,088
+69% +$312K 0.02% 333
2020
Q2 		$411K Buy
+11,717
New +$422K 0.01% 407
2013
Q4 		– Sell
-13,000
Closed -$153K – 316
2013
Q3 		$153K Buy
13,000
+500
+4% +$5.41K 0.01% 301
2013
Q2 		$116K Buy
+12,500
New +$106K 0.01% 295

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fiduciary Trust's BSX Position: Q2 2026 in Review

Fiduciary Trust increased its Boston Scientific (BSX) stake by 162% in Q2 2026, buying an estimated $1.85M and bringing the position to 54,971 shares worth $2.35M. The position accounts for 0.03% of the portfolio, ranked #261.

Fiduciary Trust first reported a position in BSX in Q2 2013 and has held it in 27 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fiduciary Trust held 54,971 shares of Boston Scientific worth $2.35M as of Q2 2026.
  • Fiduciary Trust bought 33,978 Boston Scientific shares in Q2 2026, an estimated $1.85M.
  • Boston Scientific made up 0.03% of Fiduciary Trust's portfolio in Q2 2026, its #261 holding.
  • Fiduciary Trust first reported a position in Boston Scientific in Q2 2013 and has held it in 27 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.